Inside-Filings
Projekt anfragen

Lexicon Pharmaceuticals, Inc. (LXRX)

LEXICON PHARMACEUTICALS, INC.
Healthcare · Biotechnology
TickerLXRXBörseNasdaq
ISINUS5288723027CIK0001062822
1,92
Schluss · 12.06.2026
1T+1,6 %1W+0,5 %1M−21,3 %3M+13,6 %6M+47,7 %1J+175,9 %
GCS 65 → +0,0
TSI -3,4 · 1,3 ▼ 22.05.
8-K 5.02 02.01.25· 528T
Insider ▲ 25.02.26· 109T
PDF

Glück Conviction Score™ ⓘ

LXRX LEXICON PHARMACEUTICALS, INC.
Conviction Score
65
Stark
🟢 Conviction × Timing — fundamental hohe Conviction trifft auf ein positiv drehendes Timing (Momentum/FTD). Der günstige Quadrant des Modells.
Effektiv: Stark Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
79,7
28 neu, 43 erhöht, 203,7M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

65
Technical-Score: 65 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 36.4 % — 4 bullisch / 1 bärisch / 6 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %1.90+1.3 % vs SMA50
Kurs vs SMA200Bullisch15 %1.51+27.5 % vs SMA200
EMA20 vs EMA50Bullisch5 %1.97EMA50: 1.90
MACD-HistogrammBärisch10 %-0.033Bearisch
RSI(14)Neutral10 %47.1Neutral (30–70)
Stoch %K(14)Neutral5 %25.5Neutral
ADX(14)+DINeutral10 %15.9+DI: 24.7 / −DI: 22.2
Z-Score(60)Neutral5 %0.29In Range
52W-PositionNeutral5 %70.6 %Hoch 2.44 / Tief 0.67
Bollinger(20,2σ)Neutral5 %29.1 %Upper 2.33 / Mid 2.04 / Lower 1.75
LinReg-Slope(60)Bullisch10 %+0.0089R²=0.40 / annualisiert +121.7 %

Insider-Transaktionen (12 Monate) ⓘ

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-02-25DEBBANE RAYMONDDirectorOpen Market Purchase2.0001,492.980,00+0,9%
2026-02-23DEBBANE RAYMONDDirectorOpen Market Purchase100.0001,47147.000,00+43,2%
2026-02-20DEBBANE RAYMONDDirectorOpen Market Purchase100.0001,48147.790,00+43,4%
2026-02-19DEBBANE RAYMONDDirectorOpen Market Purchase50.0001,4471.965,00+21,1%
2026-02-18DEBBANE RAYMONDDirectorOpen Market Purchase133.6881,32176.468,16+51,9%
2026-02-17DEBBANE RAYMONDDirectorOpen Market Purchase76.8571,31100.544,33+29,5%
2026-02-13DEBBANE RAYMONDDirectorOpen Market Purchase57.9521,3175.876,55+22,3%
2026-02-02Invus Global Management, LLCDirector, 10% OwnerOpen Market Purchase1.538.4621,302.000.000,60+587,7%

Fondsaktivität (Vorquartalsvergleich) ⓘ

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Artal Group S.A.154.734.327136.180.48118.553.846241.385.550Aufgestockt+13,6%
FMR LLC45.056.33837.834.2077.222.13170.287.887Aufgestockt+19,1%
Siren, L.L.C.44.303.51838.918.9035.384.61569.113.488Aufgestockt+13,8%
Sessa Capital IM, L.P.17.912.9613.000.00014.912.96127.944.219Aufgestockt+497,1%
VANGUARD CAPITAL MANAGEMENT LLC9.519.16709.519.16714.849.901Neu+100,0%
Point72 Asset Management, L.P.7.814.606284.0257.530.58112.190.785Aufgestockt+2651,4%
VANGUARD GROUP INC9.606.54909.606.54911.047.532Neu+100,0%
MILLENNIUM MANAGEMENT LLC4.944.7314.821.733122.9987.713.780Aufgestockt+2,6%
BlackRock, Inc.3.322.2193.192.448129.7715.182.662Aufgestockt+4,1%
JANE STREET GROUP, LLC3.238.9381.828.4041.410.5345.052.743Aufgestockt+77,1%
GEODE CAPITAL MANAGEMENT, LLC3.169.1112.500.022669.0894.945.786Aufgestockt+26,8%
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.766.2641.543.2421.223.0224.315.372Aufgestockt+79,3%
UBS Group AG2.483.1823.007.237-524.0553.873.764Reduziert-17,4%
MARSHALL WACE, LLP2.376.3041.262.3671.113.9373.707.035Aufgestockt+88,2%
CIBC Bancorp USA Inc.1.800.00001.800.0002.808.000Neu+100,0%
CITADEL ADVISORS LLC1.687.3012.269.075-581.7742.632.189Reduziert-25,6%
RENAISSANCE TECHNOLOGIES LLC1.600.500263.2541.337.2462.496.780Aufgestockt+508,0%
CIBC Private Wealth Group LLC1.950.00001.950.0002.242.500Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.311.2981.055.123256.1752.045.625Aufgestockt+24,3%
TWO SIGMA INVESTMENTS, LP1.199.632637.308562.3241.871.426Aufgestockt+88,2%
GOLDMAN SACHS GROUP INC1.070.517921.204149.3131.670.007Aufgestockt+16,2%
STATE STREET CORP964.038884.73879.3001.503.899Aufgestockt+9,0%
Ishara Investments LP902.000880.00022.0001.407.120Aufgestockt+2,5%
Hennion & Walsh Asset Management, Inc.848.138901.222-53.0841.323.095Reduziert-5,9%
MACKENZIE FINANCIAL CORP772.6770772.6771.205.376Neu+100,0%
ADAR1 Capital Management, LLC750.0000750.0001.170.000Neu+100,0%
GROUP ONE TRADING LLC531.706372.908158.798829.461Aufgestockt+42,6%
BANK OF AMERICA CORP /DE/526.103102.097424.006820.720Aufgestockt+415,3%
Invesco Ltd.512.426594.883-82.457799.385Reduziert-13,9%
Compagnie Lombard Odier SCmA510.000410.000100.000795.600Aufgestockt+24,4%
NORTHERN TRUST CORP494.666412.16482.502771.679Aufgestockt+20,0%
TANG CAPITAL MANAGEMENT LLC399.7000399.700623.532Neu+100,0%
XTX Topco Ltd314.61496.090218.524490.798Aufgestockt+227,4%
MORGAN STANLEY219.862193.03526.827342.985Aufgestockt+13,9%
Catalyst Funds Management Pty Ltd207.90040.300167.600324.324Aufgestockt+415,9%
ExodusPoint Capital Management, LP268.4330268.433308.698Neu+100,0%
Headlands Technologies LLC191.322136.11355.209298.462Aufgestockt+40,6%
CITIGROUP INC166.39891.67074.728259.581Aufgestockt+81,5%
Ikarian Capital, LLC164.674164.6740256.892Unverändert0,0%
Brevan Howard Capital Management LP160.4990160.499250.378Neu+100,0%
SCOTIA CAPITAL INC.159.8310159.831249.337Neu+100,0%
Jain Global LLC154.8000154.800241.488Neu+100,0%
Hudson Bay Capital Management LP152.616100.53252.084238.081Aufgestockt+51,8%
SIMPLEX TRADING, LLC138.500104.25834.242216.060Aufgestockt+32,8%
TWO SIGMA ADVISERS, LP180.9770180.977208.124Neu+100,0%
JACOBS LEVY EQUITY MANAGEMENT, INC130.0200130.020202.831Neu+100,0%
Bridgewater Advisors Inc.82.209082.209200.590Neu+100,0%
Cerity Partners LLC110.458144.944-34.486172.314Reduziert-23,8%
Quadrature Capital Ltd110.37918.41491.965172.191Aufgestockt+499,4%
Quarry LP110.00088.00022.000171.600Aufgestockt+25,0%

Top-Fondshalter (Stand: 31.03.2026) ⓘ

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
Artal Group S.A.154.734.327136.180.481+13,6%241.385.55048,04
FMR LLC45.056.33837.834.207+19,1%70.287.88713,99
Siren, L.L.C.44.303.51838.918.903+13,8%69.113.48813,76
Sessa Capital IM, L.P.17.912.9613.000.000+497,1%27.944.2195,56
VANGUARD CAPITAL MANAGEMENT LLC9.519.1670+100,0%14.849.9012,96
Point72 Asset Management, L.P.7.814.606284.025+2651,4%12.190.7852,43
MILLENNIUM MANAGEMENT LLC4.944.7314.821.733+2,6%7.713.7801,54
BlackRock, Inc.3.322.2193.192.448+4,1%5.182.6621,03
JANE STREET GROUP, LLC3.238.9381.828.404+77,1%5.052.7431,01
GEODE CAPITAL MANAGEMENT, LLC3.169.1112.500.022+26,8%4.945.7860,98
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.766.2641.543.242+79,3%4.315.3720,86
UBS Group AG2.483.1823.007.237-17,4%3.873.7640,77
MARSHALL WACE, LLP2.376.3041.262.367+88,2%3.707.0350,74
CIBC Bancorp USA Inc.1.800.0000+100,0%2.808.0000,56
CITADEL ADVISORS LLC1.687.3012.269.075-25,6%2.632.1890,52
RENAISSANCE TECHNOLOGIES LLC1.600.500263.254+508,0%2.496.7800,50
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.311.2981.055.123+24,3%2.045.6250,41
TWO SIGMA INVESTMENTS, LP1.199.632637.308+88,2%1.871.4260,37
GOLDMAN SACHS GROUP INC1.070.517921.204+16,2%1.670.0070,33
STATE STREET CORP964.038884.738+9,0%1.503.8990,30

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026✓134335,1520
31.12.2025✓123262,8300
30.09.2025✓124261,2350
30.06.2025✓124258,3241
31.03.2025✓129273,5124
31.12.2024✓128302,5222

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
MARSHALL WACE, LLP1.262.3671.451.722
Ishara Investments LP880.0001.012.000
Point72 Asset Management, L.P.284.025326.629
OMERS ADMINISTRATION Corp273.800314.870
ExodusPoint Capital Management, LP268.433308.698
TWO SIGMA ADVISERS, LP180.977208.124
Lighthouse Investment Partners, LLC126.600145.590
Graham Capital Management, L.P.109.900126.385
Hudson Bay Capital Management LP100.532115.612
Quarry LP88.000101.200

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
UBS Group AG3.007.2372.654.315+752.1 %3.458.322
JANE STREET GROUP, LLC1.828.4041.360.574+290.8 %2.102.665
MILLENNIUM MANAGEMENT LLC4.821.733991.073+25.9 %5.544.993
GOLDMAN SACHS GROUP INC921.204861.857+1452.2 %1.059.385
ACADIAN ASSET MANAGEMENT LLC640.130603.225+1634.5 %732
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.543.242333.982+27.6 %1.774.729
BARCLAYS PLC194.743162.881+511.2 %223.954
Hennion & Walsh Asset Management, Inc.901.222122.010+15.7 %1.036.405
GEODE CAPITAL MANAGEMENT, LLC2.500.022102.099+4.3 %2.876.410
TWO SIGMA SECURITIES, LLC114.63298.751+621.8 %131.827

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
FMR LLC37.834.207-845.541-2.2 %43.509.338
CITADEL ADVISORS LLC2.269.075-819.152-26.5 %2.609.436
Schonfeld Strategic Advisors LLC13.108-812.525-98.4 %15.072
ROYAL BANK OF CANADA6.768-715.667-99.1 %7.000
CIBC Private Wealth Group LLC1.950.000-450.257-18.8 %2.242.500
XTX Topco Ltd96.090-233.446-70.8 %110.504
Monaco Asset Management SAM117.188-232.812-66.5 %134.766
Quadrature Capital Ltd18.414-209.795-91.9 %21.176
GSA CAPITAL PARTNERS LLP996.235-206.671-17.2 %1.146
BlackRock, Inc.3.192.448-202.524-6.0 %3.671.316

Aktivisten & Großaktionäre (13D/13G) ⓘ

DatumInvestorTypAnteilAktienΔZweck
09.05.2026Artal International Management S.A.Aktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Westend S.A.Aktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus Global Management, LLCAktivist (13D/A)9,60 %42.765.057-0,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Ulys, L.L.C.Aktivist (13D/A)1,60 %6.989.6660,00 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Avicenna Life Sci Master GP LLCAktivist (13D/A)0,30 %1.538.462-0,10 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Artal Group S.A.Aktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Siren, L.L.C.Aktivist (13D/A)9,60 %42.765.057-0,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus Public Equities, L.P.Aktivist (13D/A)1,70 %7.362.3680,00 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus, L.P.Aktivist (13D/A)9,60 %42.765.057-0,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus US Partners LLCAktivist (13D/A)1,20 %5.451.204-0,10 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Stichting Administratiekantoor WestendAktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Amaury WittouckAktivist (13D/A)39,40 %175.156.062NeuItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus Public Equities Advisors, LLCAktivist (13D/A)1,70 %7.362.3680,00 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Avicenna Life Sci Master Fund LPAktivist (13D/A)0,30 %1.538.462-0,10 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Raymond DebbaneAktivist (13D/A)11,70 %51.878.643NeuItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Invus Advisors, L.L.C.Aktivist (13D/A)9,60 %42.765.057-0,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Artal International S.C.A.Aktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
09.05.2026Artal Participations S.a r.l.Aktivist (13D/A)39,40 %175.156.062+3,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: As previously di…
02.02.2026Ulys, L.L.C.Aktivist (13D/A)1,60 %6.989.666NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Artal Group S.A.Aktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Westend S.A.Aktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Stichting Administratiekantoor WestendAktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Artal International Management S.A.Aktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Artal Participations S.a r.l.Aktivist (13D/A)36,20 %154.734.327NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Avicenna Life Sci Master GP LLCAktivist (13D/A)0,40 %1.538.462NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus Public Equities Advisors, LLCAktivist (13D/A)1,70 %7.362.368-0,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Avicenna Life Sci Master Fund LPAktivist (13D/A)0,40 %1.538.462NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus Public Equities, L.P.Aktivist (13D/A)1,70 %7.362.368-0,20 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Siren, L.L.C.Aktivist (13D/A)10,00 %42.765.057NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus US Partners LLCAktivist (13D/A)1,30 %5.451.204-1,60 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Mr. Amaury WittouckAktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus Global Management, LLCAktivist (13D/A)10,00 %42.765.057NeuItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Mr. Raymond DebbaneAktivist (13D/A)12,00 %51.217.900+8,90 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus, L.P.Aktivist (13D/A)10,00 %42.765.057-10,60 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Artal International S.C.A.Aktivist (13D/A)36,20 %154.734.327-11,40 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
02.02.2026Invus Advisors, L.L.C.Aktivist (13D/A)10,00 %42.765.057-10,60 ppItem 4 of the Statement is hereby amended and supplemented as follows: The information …
08.07.2025FMR LLCPassiv (13G/A)10,50 %38.137.535+0,90 pp
08.07.2025Abigail P. JohnsonPassiv (13G/A)10,50 %38.137.535+0,90 pp
12.05.2025Abigail P. JohnsonPassiv (13G/A)9,60 %34.543.197Neu
12.05.2025FMR LLCPassiv (13G/A)9,60 %34.543.197Neu

Stammdaten

Lexicon Pharmaceuticals, Inc., ein Biopharmaunternehmen, konzentriert sich auf die Entdeckung, Entwicklung und Vermarktung von Pharmaprodukten. Seine oralen Wirkstoffkandidaten in Entwicklung umfassen Sotagliflozin, das Phase-III-Studien für die Behandlung von Herzinsuffizienz und Typ-1-Diabetes abgeschlossen hat; und LX9211, das sich in Phase-II-klinischer Entwicklung zur Behandlung von neuropathischen Schmerzen befindet. Das Unternehmen hat strategische Kooperations- und Lizenzierungsverträge mit Bristol-Myers Squibb Company und Genentech, Inc. Lexicon Pharmaceuticals, Inc. wurde 1995 gegründet und hat seinen Sitz in The Woodlands, Texas.

Unternehmen & Branche

NameLEXICON PHARMACEUTICALS, INC.
TickerLXRX
CIK0001062822
BoerseNasdaq
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP528872302
ISINUS5288723027
TypCommon Stock
Marktkapitalisierung687,8 Mio. USD
Beta0,97

Bewertung

KBV (P/B)6,40 vs. 5,05 (2021) ▲
KUV (P/S)13,81 vs. 1.925,73 (2021) ▼
FCF-Rendite-9,9 % vs. -15,4 % (2021) ▲

Qualität & Bilanz

Bruttomarge99,4 % vs. 100,0 % (2021) ≈
Operative Marge-98,2 % vs. -29.224,8 % (2021) ▲
Nettomarge-101,1 % vs. -29.449,0 % (2021) ▲
ROIC-29,7 % vs. -76,5 % (2021) ▲

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025Verlauf
Bewertung
KBV (P/B)5,052,703,631,843,91
KUV (P/S)1.925,732.277,34281,008,638,45
FCF-Rendite-15,4 %-28,5 %-48,0 %-67,1 %-16,1 %
Buyback-Rendite0,5 %0,3 %0,2 %0,6 %–
Qualität & Bilanz
Bruttomarge100,0 %100,0 %92,9 %98,0 %99,4 %
Operative Marge-29.224,8 %-72.489,2 %-14.265,0 %-634,2 %-98,2 %
Nettomarge-29.449,0 %-73.341,0 %-14.710,9 %-644,8 %-101,1 %
ROIC-76,5 %-59,1 %-88,9 %-79,5 %-29,7 %
Zinsdeckungsgrad-108,6-36,2–––

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL) ⓘ

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q21.102.000-1.043.0000,00268.819.000202.856.000
2025-12-3110-K49.803.000-50.341.000-0,14184.987.000107.538.000
2025-09-3010-Q14.182.000-12.769.000-0,04205.927.000120.159.000
2025-06-3010-Q28.866.0003.252.0000,01225.583.000129.440.000
2025-03-3110-Q1.262.000-25.295.000-0,07297.671.000123.032.000
2024-12-3110-K31.081.000-200.403.000-0,63298.420.000145.950.000
2024-09-3010-Q1.750.000-64.811.000-0,18321.123.000178.512.000
2024-06-3010-Q1.647.000-53.429.000-0,17373.356.000239.980.000
2024-03-3110-Q1.130.000-48.397.000-0,20417.219.000288.867.000
2023-12-3110-K1.204.000-177.119.000-0,80229.429.00093.110.000
2023-09-3010-Q162.000-50.525.000-0,21276.479.000139.510.000
2023-06-3010-Q317.000-44.904.000-0,22316.724.000186.361.000
2023-03-3110-Q24.000-31.934.000-0,17162.716.00088.046.000
2022-12-3110-K139.000-101.944.000-0,62194.299.000117.124.000
2022-09-3010-Q39.000-23.387.000-0,13191.685.000144.018.000
2022-06-3010-Q35.000-24.587.000112.325.00070.830.000
2022-03-3110-Q-23.476.000136.178.00092.698.000
2021-12-3110-K298.000-87.758.000-0,60136.909.000113.595.000
2021-09-3010-Q23.000-23.122.000-0,16172.330.000136.603.000
2021-06-3010-Q234.000-18.067.000171.672.000137.233.000

Umsatz nach Segmenten & Regionen ⓘ

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022AnteilΔTrend
License45,0 Mio.–––90,6 %Neu
Product4,6 Mio.–––9,4 %Neu
Reportable Segment–6,0 Mio.1,1 Mio.139.000––

Quartalsergebnisse (Earnings) ⓘ

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202607.05.202621,1 Mio. USD0,00
Q3 202530.09.202506.11.202514,2 Mio. USD-0,04
Q2 202530.06.202506.11.202528,9 Mio. USD0,01
Q1 202531.03.202507.05.20261,3 Mio. USD-0,07
Q3 202430.09.202406.11.20251,8 Mio. USD-0,18
Q2 202430.06.202406.11.20251,6 Mio. USD-0,17
Q1 202431.03.202406.11.20251,1 Mio. USD-0,20
Q3 202330.09.202313.11.2024162.000 USD-0,21
Q2 202330.06.202313.11.2024317.000 USD-0,22

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
07.05.2026 10-Q – – SEC »
05.03.2026 10-K 31.12.2025 64 Tage SEC »
06.11.2025 10-Q 30.09.2025 37 Tage SEC »
06.08.2025 10-Q 30.06.2025 37 Tage SEC »
14.05.2025 10-Q 31.03.2025 44 Tage SEC »
07.03.2025 10-K 31.12.2024 66 Tage SEC »
13.11.2024 10-Q 30.09.2024 44 Tage SEC »
02.08.2024 10-Q 30.06.2024 33 Tage SEC »
02.05.2024 10-Q 31.03.2024 32 Tage SEC »
25.03.2024 10-K 31.12.2023 85 Tage SEC »
08.11.2023 10-Q 30.09.2023 39 Tage SEC »
04.08.2023 10-Q 30.06.2023 35 Tage SEC »
04.05.2023 10-Q 31.03.2023 34 Tage SEC »
03.03.2023 10-K 31.12.2022 62 Tage SEC »
09.11.2022 10-Q 30.09.2022 40 Tage SEC »
03.08.2022 10-Q 30.06.2022 34 Tage SEC »
05.05.2022 10-Q 31.03.2022 35 Tage SEC »
10.03.2022 10-K 31.12.2021 69 Tage SEC »
09.11.2021 10-Q 30.09.2021 40 Tage SEC »
06.08.2021 10-Q 30.06.2021 37 Tage SEC »
06.05.2021 10-Q 31.03.2021 36 Tage SEC »
12.03.2021 10-K 31.12.2020 71 Tage SEC »
30.10.2020 10-Q 30.09.2020 30 Tage SEC »
29.07.2020 10-Q 30.06.2020 29 Tage SEC »

Kritische 8-K Meldungen ⓘ

DatumMeldungSchwereFilingAuszug
02.01.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors…
20.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
16.09.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors…
08.07.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors…
29.04.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors…
11.10.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
31.07.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors…
24.07.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
09.09.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
02.08.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
01.04.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
04.08.2020Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory…

Fail-to-Deliver (6 Monate) ⓘ

DatumFTD-MengeKursWert (USD)
2026-05-131.5272,413.680
2026-05-085.7591,689.675
2026-03-0618.9361,6431.055
2026-03-021.5111,472.221
2026-02-271.5141,502.271
2026-02-267.5251,5011.288
2026-02-2011,522
2026-01-294631,50695
2026-01-284631,71792
2026-01-2212.3091,5619.202
2026-01-202.8001,373.836
2026-01-1612.3351,2815.789
2026-01-093.8571,184.551
2026-01-073.2751,143.733
2026-01-0528.9321,1432.982
2025-12-308.0001,179.360
2025-12-24292.3781,21353.777
2025-12-23262.7291,22320.529
2025-12-22266.8961,17312.268
2025-12-159.0961,3011.825

Hinweis

Erweitert ×